Physician variation in the management of patients with atrial fibrillation

Heart

Volumn 75, Issue 2, 1996, Pages 200-205

  Lip, Gregory Y H ^a   Zarifis, John ^a   Watson, Robert D S ^a   Beevers, D Gareth ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Atrial fibrillation; Physician variation; Questionnaire; Survey

Indexed keywords

ANTIARRHYTHMIC AGENT; DIGOXIN; HEPARIN;

ARTICLE; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HUMAN; OBSERVER VARIATION; PRIORITY JOURNAL; QUESTIONNAIRE; THROMBOEMBOLISM;

EID: 0030046318     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.2.200     Document Type: Article

References (24)

1. Lip GYH, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. Br Heart J 1994;71: 92-5.
2. Bath PMW, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. BMJ 1993;307:1045.
3. Hendry A, Campbell AM, Campbell G, Macdonald JB, Williams BO. Antithrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation. Scott Med J 1994;39:110-1.
4. Chang HJ, Bell JR, Deroo DB, Kirk JW, Wasson JH. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med 1990;150:83-6.
5. Lowe GDO. Antithrombotic treatment and atrial fibrillation. BMJ 1992;305:1445-6.
6. Atrial fibrillation investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomised controlled trials. Arch Intern Med 1994;154:1449-57.
7. Stroke prevention in atrial fibrillation investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study. Lancet 1994;343:687-91.
8. Brook RH, Park RE, Winslow CM, Kosecoff JB, Chassin MR, Hampton JR. Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK. Lancet 1988;i:750-3.
9. Stroke prevention in atrial fibrillation investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992; 116:1-5.
10. Stroke prevention in atrial fibrillation investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
11. Petersen P. Thromboembolic complications in atrial fibrillation. Stroke 1990;21:4-13.
12. Petersen P. Thromboembolic complications of atrial fibrillation and their prevention: a review. Am J Cardiol 1990; 65:24-28C.
13. Selzer A. Atrial fibrillation revisited. N Engl J Med 1982; 306:1044-5.
14. Sobel BE. Thrombolysis in the treatment of acute myocardial infarction. In: Fuster V, Verstraete M, ed. Thrombosis in cardiovascular disorders. Philadelphia: WB Saunders, 1992:289-326.
15. Turpie AGG, Robinson JH, Doule DJ, et al. Comparison of high dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction. N Engl J Med 1989;320:352-7.
16. Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: natural history, complications, and management. Annu Rev Med 1988;39:41-52.
17. Dittrich HC, Erickson JS, Schneidermen T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989;63:193-7.
18. ACP/ACC/AHA Task Force Statement. Clinical competence in elective direct current (DC) cardioversion. J Am Coll Cardiol 1993;22:336-9.
19. O'Neill PG, Puleo PR, Bolli R, Rokey R. Return of atrial mechanical function following electrical cardioversion of atrial arrhythmias. Am Heart J 1990;120:353-9.
20. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994;23:1535-40.
21. Dunn M, Alexander J, de Silva R, Hildner F. Antithrombotic therapy in atrial fibrillation. Chest 1989; 95:118-27S.
22. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317: 669-74.
23. Brand FN, Abbott RD, Kannel WB, Wolf PF. Characteristics and prognosis of lone atrial fibrillation: 30-year follow up in the Framingham study. JAMA 1985;254:3449-53.
24. Caro JJ, Groome PA, Flegel KM. Atrial fibrillation and anticoagulation: from randomised trials to practice. Lancet 1993;341:1381-4.